Author

Halime Meryem Soylu

Observed names: Halime Soylu, Meryem Soylu

Institutions: Queens Hospital Center, Mount Sinai Queens, Icahn School of Medicine at Mount Sinai

Observed institutions: University of California San Diego, Queens Hospital Center, Mount Sinai Queens, Moores Cancer Center, Istanbul University, Icahn School of Medicine at Mount Sinai

ORCID: 0000-0003-1088-624X

Observed ORCID: 0000-0003-1088-624X

OpenAlex ID: A5041635553

Improvement in quality of life and pain scores after laparoscopic management of deep endometriosis: a retrospective cohort study

2020 · Ercan Bastu, Hale Goksever Celik, et al. · Archives of Gynecology and Obstetrics · 15

Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al. · Cancer Research Communications · 7

References Supporting Recommendations in Obstetrical Green Top Guidelines: An Overview of RCOG Clinical Guidelines

2025 · Halime Meryem Soylu, Hector Mendez-Figueroa, et al. · American Journal of Perinatology · 1

Evaluation of the Quality of Evidence Supporting Obstetrical Recommendations in ACOG Practice Bulletins and RCOG Green Top Guidelines [ID 1034]

2025 · Halime Soylu, Hector Mendez-Figueroa, et al. · Obstetrics and Gynecology

Figure 3 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Figure 7 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Data from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Figure 1 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Figure 6 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Figure 5 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Figure 4 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

Figure 2 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma

2024 · Yichi Zhang, Marjaana Ojalill, et al.

RAS/RAF/MEK mutated high-grade serous ovarian cancer susceptible to Raf inhibition in vitro but not in vivo

2024 · Ioana Bondre, Breana Hill, et al. · Gynecologic Oncology

Focal adhesion kinase inhibitors as maintenance therapy in a homologous recombination repair proficient high-grade serous ovarian cancer murine model

2024 · Breana Hill, Ioana Bondre, et al. · Gynecologic Oncology

38 Use of postoperative opioids in patients undergoing robotic hysterectomy for endometrial cancer with or without abdominal wall block

2023 · Ioana L. Bondre, Breana L. Hill, et al. · Gynecologic Oncology Reports

37 HPV vaccination rates among women 27–45 rose more slowly after ACOG's statement recommending shared decision making

2023 · Ioana L. Bondre, Halime Meryem Soylu, et al. · Gynecologic Oncology Reports

Tu1589 A LONGITUDINAL ASSESSMENT OF APRI AND FIB-4 IN URSODEOXYCHOLIC ACID-RESPONDER AND NON-RESPONDER PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

2023 · Nazli Begum Ozturk, Halime Meryem Soylu, et al. · Gastroenterology

Works count: 17

Citation count: 23

H-index: 2

I10-index: 1